×
T2 Biosystems EBITDA 2013-2024 | TTOO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
T2 Biosystems ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
T2 Biosystems EBITDA 2013-2024 | TTOO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
T2 Biosystems ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$174B
Intuitive Surgical (ISRG)
$168.5B
IDEXX Laboratories (IDXX)
$52.6B
Edwards Lifesciences (EW)
$46B
Alcon (ALC)
$42.3B
DexCom (DXCM)
$30.9B
IQVIA Holdings (IQV)
$30.6B
Mettler-Toledo (MTD)
$25.9B
STERIS (STE)
$23.9B
Waters (WAT)
$16.7B
SONOVA HOLDING (SONVY)
$16.6B
Hologic (HOLX)
$15.1B
Penumbra (PEN)
$9.4B
Sysmex ADR (SSMXY)
$8.7B
Globus Medical (GMED)
$7.9B
Masimo (MASI)
$7.9B
Teleflex (TFX)
$5.2B
Glaukos (GKOS)
$4.9B
TransMedics (TMDX)
$3.9B
Integer Holdings (ITGR)
$3.7B
LivaNova (LIVN)
$2.7B
Alphatec Holdings (ATEC)
$2.2B
Veracyte (VCYT)
$2.2B
PROCEPT BioRobotics (PRCT)
$2.1B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.9B
Artivion (AORT)
$1.7B
Paragon 28 (FNA)
$1.1B
Integra LifeSciences Holdings (IART)
$1B
OPKO Health (OPK)
$992M